Entheon Biomedical Corp. reported earnings results for the first quarter ended February 28, 2022. For the first quarter, the company reported sales was CAD 0.008901 million. Net loss was CAD 1.87 million compared to CAD 2.88 million a year ago. Basic loss per share from continuing operations was CAD 0.03 compared to CAD 0.06 a year ago. Diluted loss per share from continuing operations was CAD 0.03 compared to CAD 0.06 a year ago.